Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.58 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | PPARA | Q07869 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8661488 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL28052567 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL815030 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL28862751 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL28237611 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL28237567 | 1.00 | FAAH (0.58) | FAAHTRPV1TERTPTPN1PPARG | |
| Ammonia Solution, Strong SCHEMBL7641977 | 0.97 | FAAH (0.56) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL25220064 | 0.95 | FAAH (0.52) | FAAHTRPV1TERTPTPN1PPARG | |
| SCHEMBL814070 | 0.93 | TRPV1 (0.57) | FAAHTRPV1PPARGPPARDPPARA | |
| SCHEMBL12917418 | 0.93 | TRPV1 (0.57) | FAAHTRPV1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2321363-B1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | MATERIA INC (US) | 2020-04-22 | — | — | EP | disclosed |
| EP-2046719-B1 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | ELEVANCE RENEWABLE SCIENCES (US) | 2013-09-04 | — | — | EP | disclosed |
| US-8324334-B2 | Telechelic olefin metathesis polymers from renewable feedstocks | MATERIA, INC. (US) | 2012-12-04 | — | — | US | disclosed |
| US-8067623-B2 | Producing waxes from soybean oil; ruthenium alkylidene catalytic, simultaneous opening and inserting | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2011-11-29 | — | — | US | disclosed |
| EP-2321363-A1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | Materia, Inc. (US) | 2011-05-18 | — | — | EP | disclosed |
| WO-2010021740-A1 | TELECHELIC OLEFIN METATHESIS POLYMERS FROM RENEWABLE FEEDSTOCKS | MATERIA, INC. (US) | 2010-02-25 | — | — | WO | disclosed |
| EP-2046719-A2 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | Elevance Renewable Sciences, Inc. (US) | 2009-04-15 | — | — | EP | disclosed |
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | WILMAR TRADING PTE LTD (SG) | 2008-03-13 | — | — | US | disclosed |
| WO-2008008440-A2 | RING OPENING CROSS-METATHESIS REACTION OF CYCLIC OLEFINS WITH SEED OILS AND THE LIKE | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| EP-0882010-A1 | PHARMACEUTICAL AGENTS CONTAINING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THE USE THEREOF IN TUMOUR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-12-09 | — | — | EP | disclosed |
| EP-0874645-A2 | PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THEIR USE IN NMR DIAGNOSTICS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-11-04 | — | — | EP | disclosed |
| WO-1997030969-A1 | PHARMACEUTICAL AGENTS CONTAINING PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THE USE THEREOF IN TUMOUR THERAPY AND INTERVENTIONAL RADIOLOGY | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-08-28 | — | — | WO | disclosed |
| WO-1997026017-A2 | PERFLUOROALKYL-CONTAINING METAL COMPLEXES AND THEIR USE IN NMR DIAGNOSTICS | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-07-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064891-A1 | Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like | SQLE, COASY, ALOX12 | FAAH 307/4885TRPV1 3404/4885TERT 533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.